Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation

Alex Zheleznyak, Thaddeus Wadas, Christopher Sherman, Paul Kostenuik and Carolyn Anderson
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1958;
Alex Zheleznyak
1Washington University School of Medicine, Mallincrodt Institute of Radiology, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thaddeus Wadas
1Washington University School of Medicine, Mallincrodt Institute of Radiology, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Sherman
1Washington University School of Medicine, Mallincrodt Institute of Radiology, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Kostenuik
2Amgen, Inc, Thousand Oaks, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Anderson
1Washington University School of Medicine, Mallincrodt Institute of Radiology, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 1958

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Alex Zheleznyak1,
  2. Thaddeus Wadas1,
  3. Christopher Sherman1,
  4. Paul Kostenuik2 and
  5. Carolyn Anderson1
  1. 1Washington University School of Medicine, Mallincrodt Institute of Radiology, Saint Louis, MO
  2. 2Amgen, Inc, Thousand Oaks, CA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2015 to April 2025

AbstractFullPdf
Jan 2015100
Feb 2015200
Mar 2015100
Jun 2015100
Sep 2015300
Oct 2015100
Nov 2015100
Dec 2015100
Jan 2016400
Mar 2016400
Apr 2016200
May 2016100
Jun 2016400
Jan 2017100
Feb 2017200
Apr 2017500
May 2017400
Jun 2017600
Jul 2017100
Aug 2017200
Sep 2017200
Oct 2017300
Nov 2017100
Apr 2018100
Sep 2018400
Oct 2018100
Nov 2018100
Jan 2019200
Mar 2019100
Apr 2019100
Jun 2019300
Jul 2019100
Sep 2019100
Jan 2020200
Aug 2020300
Oct 2020100
Dec 2020500
Feb 2021900
Mar 2021700
Apr 2021800
May 2021400
Jun 20211300
Jul 202111300
Aug 202114000
Sep 2021500
Oct 2021100
Nov 2021100
Dec 2021300
Jan 2022200
Feb 2022300
Mar 2022300
Apr 2022300
May 2022100
Jun 2022100
Aug 2022100
Sep 2022100
Nov 2022100
Jan 2023300
Feb 2023100
Mar 2023400
Apr 2023200
May 2023100
Jun 2023200
Jul 2023400
Aug 2023100
Sep 2023200
Oct 2023200
Nov 2023500
Dec 2023400
Jan 2024500
Feb 2024100
Mar 2024500
Apr 20242200
May 2024600
Jun 2024100
Jul 2024200
Aug 20241300
Sep 20242000
Oct 2024100
Nov 2024400
Dec 20241300
Feb 2025400
Mar 2025100
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation
Alex Zheleznyak, Thaddeus Wadas, Christopher Sherman, Paul Kostenuik, Carolyn Anderson
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1958;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation
Alex Zheleznyak, Thaddeus Wadas, Christopher Sherman, Paul Kostenuik, Carolyn Anderson
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1958;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Application of radioiodinated (2S,αS)-2-[α-(2-iodophenoxy)benzyl]morpholine to neuroendocrine tumor imaging.
  • Metabolism of DPA-714, a new peripheral benzodiazepine receptor PET ligand
  • A novel method of separation of 99mTc from (n, γ) 99Mo of low/medium specific activity based on solid phase column extraction technique: Suitablity for use in diagnostic radiopharmaceuticals
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

New Radiopharmaceuticals-Novel Probe Development Posters

  • Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
Show more New Radiopharmaceuticals-Novel Probe Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire